Consortium of Indigenous Fecal Bacteria in the Treatment of Metabolic Syndrome.
Bacteroides fragilis
Bifidobacterium spp.
Lactobacillus spp.
autoprobiotics
dyslipidemia
eating disorders
indigenous consortium
obesity
Journal
Microorganisms
ISSN: 2076-2607
Titre abrégé: Microorganisms
Pays: Switzerland
ID NLM: 101625893
Informations de publication
Date de publication:
05 Aug 2022
05 Aug 2022
Historique:
received:
30
06
2022
revised:
22
07
2022
accepted:
24
07
2022
entrez:
26
8
2022
pubmed:
27
8
2022
medline:
27
8
2022
Statut:
epublish
Résumé
The features of gut microbiota in metabolic syndrome (MS) and ways to correct it using autoprobiotics, based on indigenous bacteria obtained from fecal samples of the host, remain unexplored. The aim of the study was to investigate the effectiveness of an indigenous consortium (IC) of fecal bacteria in treatment of patients with MS. The study was carried out on 36 patients with MS, manifested with abdominal obesity, eating disorders, dyslipidemia, and hypertension. The control group was formed by 20 healthy volunteers. Samples of IC and gut microbiota content were examined by qPCR and metagenome (16S rRNA) analysis before and after therapy. The decrease in anthropometric parameters of obesity, liver enzyme level correction, reduction in C reactive protein and triglyceride concentrations were revealed after IC usage. The decrease in genera
Identifiants
pubmed: 36013992
pii: microorganisms10081574
doi: 10.3390/microorganisms10081574
pmc: PMC9414820
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Gut Microbes. 2021 Jan-Dec;13(1):1987783
pubmed: 34693878
Appl Environ Microbiol. 2006 Jul;72(7):5069-72
pubmed: 16820507
Clin Endosc. 2021 Mar;54(2):157-160
pubmed: 33827154
Gut Microbes. 2017 May 4;8(3):253-267
pubmed: 28609252
Front Microbiol. 2018 May 07;9:890
pubmed: 29867803
Trends Microbiol. 2016 Jul;24(7):523-524
pubmed: 26996766
World J Gastroenterol. 2014 Nov 21;20(43):16079-94
pubmed: 25473159
Front Microbiol. 2018 Sep 12;9:1869
pubmed: 30258408
Inflamm Bowel Dis. 2012 Apr;18(4):676-84
pubmed: 21618362
Environ Microbiol. 2017 Mar;19(3):835-841
pubmed: 28028921
Expert Rev Clin Pharmacol. 2018 Jun;11(6):545-547
pubmed: 29667442
Eur J Nutr. 2021 Mar;60(2):655-663
pubmed: 32417946
Chin Med J (Engl). 2020 Apr 5;133(7):808-816
pubmed: 32106124
Genome Biol. 2016 Sep 26;17(1):189
pubmed: 27666579
PLoS Med. 2020 Mar 9;17(3):e1003051
pubmed: 32150549
Ann Med. 2004;36(5):332-46
pubmed: 15478308
J Diet Suppl. 2019;16(3):294-306
pubmed: 29672196
JAMA. 2013 Nov 27;310(20):2191-4
pubmed: 24141714
Food Res Int. 2019 Dec;126:108590
pubmed: 31732047
Gut. 2009 Aug;58(8):1091-103
pubmed: 19240062
Microorganisms. 2021 Mar 04;9(3):
pubmed: 33806341
Sci Rep. 2021 Jan 12;11(1):659
pubmed: 33436764
Nat Med. 2019 May;25(5):716-729
pubmed: 31061539
Lancet. 2005 Apr 16-22;365(9468):1415-28
pubmed: 15836891
Mol Microbiol. 2014 Dec;94(6):1361-74
pubmed: 25339613
Clin Microbiol Rev. 2007 Oct;20(4):593-621
pubmed: 17934076
Int J Med Microbiol. 2016 Aug;306(5):302-309
pubmed: 27012594